327 related articles for article (PubMed ID: 8463110)
1. Ecological analysis of the first generation of community clinical oncology programs.
Schopler JH
Health Serv Res; 1993 Apr; 28(1):69-95. PubMed ID: 8463110
[TBL] [Abstract][Full Text] [Related]
2. Predicting the performance of a strategic alliance: an analysis of the Community Clinical Oncology Program.
Kaluzny AD; Lacey LM; Warnecke R; Hynes DM; Morrissey J; Ford L; Sondik E
Health Serv Res; 1993 Jun; 28(2):159-82. PubMed ID: 8514498
[TBL] [Abstract][Full Text] [Related]
3. Performance in quasi-firms: an example from the Community Clinical Oncology Program.
Lacey LM; Hynes DM; Kaluzny AD
J Health Hum Resour Adm; 1992; 14(3):307-26. PubMed ID: 10118501
[TBL] [Abstract][Full Text] [Related]
4. The NCI All Ireland Cancer Conference.
Johnston PG; Daly PA; Liu E
Oncologist; 1999; 4(4):275-277. PubMed ID: 10545862
[TBL] [Abstract][Full Text] [Related]
5. Interorganizational exchanges as performance markers in a community cancer network.
McKinney MM; Morrissey JP; Kaluzny AD
Health Serv Res; 1993 Oct; 28(4):459-78. PubMed ID: 8407338
[TBL] [Abstract][Full Text] [Related]
6. Using a community cancer treatment trials network for cancer prevention and control research: challenges and opportunities.
Kaluzny AD; Lacey LM; Warnecke R; Morrissey JP; Sondik E; Ford L
Cancer Epidemiol Biomarkers Prev; 1994; 3(3):261-9. PubMed ID: 8019377
[TBL] [Abstract][Full Text] [Related]
7. The effects of managed care and competition on community-based clinical research.
Carpenter WR; Weiner BJ; Kaluzny AD; Domino ME; Lee SY
Med Care; 2006 Jul; 44(7):671-9. PubMed ID: 16799362
[TBL] [Abstract][Full Text] [Related]
8. Recruiting participants to cancer prevention clinical trials: lessons from successful community oncology networks.
McKinney MM; Weiner BJ; Wang V
Oncol Nurs Forum; 2006 Sep; 33(5):951-9. PubMed ID: 16955123
[TBL] [Abstract][Full Text] [Related]
9. Research-design issues in cancer-symptom-management trials using complementary and alternative medicine: lessons from the National Cancer Institute Community Clinical Oncology Program experience.
Buchanan DR; White JD; O'Mara AM; Kelaghan JW; Smith WB; Minasian LM
J Clin Oncol; 2005 Sep; 23(27):6682-9. PubMed ID: 16170176
[TBL] [Abstract][Full Text] [Related]
10. Increasing minority participation in cancer clinical trials: the minority-based community clinical oncology program experience.
McCaskill-Stevens W; McKinney MM; Whitman CG; Minasian LM
J Clin Oncol; 2005 Aug; 23(22):5247-54. PubMed ID: 16051967
[TBL] [Abstract][Full Text] [Related]
11. Cancer control research for community programs: the National Cancer Institute initiative.
Hunter CP; Bavier AR; Ford LG
Cancer Detect Prev; 1990; 14(6):633-7. PubMed ID: 2257561
[TBL] [Abstract][Full Text] [Related]
12. Adapting clinical trials networks to promote cancer prevention and control research.
Weiner BJ; McKinney MM; Carpenter WR
Cancer; 2006 Jan; 106(1):180-7. PubMed ID: 16333855
[TBL] [Abstract][Full Text] [Related]
13. Trends in program project grant funding at the National Cancer Institute.
Broder S; Cushing M
Cancer Res; 1993 Feb; 53(3):477-84. PubMed ID: 8425180
[TBL] [Abstract][Full Text] [Related]
14. Head and neck cancer care at a community-based teaching hospital.
Witt RL; Frelick RW
Head Neck; 2005 Jul; 27(7):613-5. PubMed ID: 15825202
[TBL] [Abstract][Full Text] [Related]
15. Organizations and structures that facilitate community research.
Coltman CA
Semin Oncol; 1994 Aug; 21(4 Suppl 7):107-11. PubMed ID: 8091235
[TBL] [Abstract][Full Text] [Related]
16. Organizational and client determinants of cost in outpatient substance abuse treatment.
Beaston-Blaakman A; Shepard D; Horgan C; Ritter G
J Ment Health Policy Econ; 2007 Mar; 10(1):3-13. PubMed ID: 17417043
[TBL] [Abstract][Full Text] [Related]
17. The study of client-provider interactions: a review of methodological issues.
Simmons R; Elias C
Stud Fam Plann; 1994; 25(1):1-17. PubMed ID: 8209391
[TBL] [Abstract][Full Text] [Related]
18. Results of the ACSUS for pediatric AIDS patients: utilization of services, functional status, and social severity.
Fahs MC; Waite D; Sesholtz M; Muller C; Hintz EA; Maffeo C; Arno P; Bennett C
Health Serv Res; 1994 Dec; 29(5):549-68. PubMed ID: 8002349
[TBL] [Abstract][Full Text] [Related]
19. Procedures and methods of benefit assessments for medicines in Germany.
Bekkering GE; Kleijnen J
Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905
[TBL] [Abstract][Full Text] [Related]
20. Assessing the quality of healthcare provided to children.
Mangione-Smith R; McGlynn EA
Health Serv Res; 1998 Oct; 33(4 Pt 2):1059-90. PubMed ID: 9776949
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
